To Use or Not to Use: Temozolomide in Elderly Patients with IDH Wild-type MGMT Promoter Unmethylated Glioblastoma Treated with Radiotherapy [0.03%]
使用与否：老年患者IDH野生型MGMT启动子未甲基化胶质母细胞瘤放射治疗后使用替莫唑胺治疗
Chan Woo Wee,Joo Ho Lee,Hye In Lee et al.
Chan Woo Wee et al.
Purpose: To identify a specific subgroup of patients among elderly glioblastoma patients aged 70 years or older with unmethylated MGMT promoters (eGBM-unmethylated) who would significantly benefit from the addition of tem...
Predictive Value of the nProfiler 1 Assay for the Efficacy of Adjuvant S-1-Based Doublet Chemotherapy in Stage III Gastric Cancer: A Post-Hoc Analysis of a Randomized Phase III Trial [0.03%]
nProfiler 1检测对III期胃癌辅助S-1双药化疗有效性的预测价值：一项随机Ⅲ期临床试验的事后分析研究
Dong Ki Lee,Choong-Kun Lee,Hyo Song Kim et al.
Dong Ki Lee et al.
Purpose: The nProfiler 1 Stomach Cancer Assay (nProfiler1), designed to predict responses to fluorouracil-based adjuvant chemotherapy, measures the expression of four gastric cancer target genes (GZMB, WARS, SFRP4, and CD...
Commentary on "Metronomic S-1 Adjuvant Chemotherapy Improves Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma" [0.03%]
关于“序贯S-1新辅助化疗改善局部区域晚期鼻咽癌患者生存前景”的点评
Erkan Topkan,Efsun Somay,Nilufer Kılıc Durankus et al.
Erkan Topkan et al.
Time-Trend Analysis and Risk Factors for Niraparib-Induced Nausea and Vomiting in Ovarian Cancer: A Prospective Study [0.03%]
尼拉帕利致恶心呕吐的时间趋势和危险因素分析——一项前瞻性研究
Young Wook Jeong,Dongkyu Eugene Kim,Ji Hyun Kim et al.
Young Wook Jeong et al.
Purpose: Nausea and vomiting are major non-hematological adverse events associated with niraparib maintenance therapy. This study aimed to investigate the time-trend patterns of niraparib-induced nausea and vomiting (NINV...
Fraction of Cancer Attributable to Carcinogenic Drugs in Korea from 2015 to 2030 [0.03%]
2015至2030年致癌药物导致的癌症负担估算——基于韩国人群数据
Woojin Lim,Soseul Sung,Youjin Hong et al.
Woojin Lim et al.
Purpose: This study aims to estimate and project the Population Attributable Fraction (PAF) of cancer incidence and death due to carcinogenic drug use in Korea from 2015 to 2030, to estimate the degree of cancer preventio...
Low‒Dose Cyclophosphamide Enhances the Tumoricidal Effects of 5-Day Spacing Stereotactic Ablative Radiotherapy by Boosting Antitumor Immunity [0.03%]
低剂量环磷酰胺通过增强抗肿瘤免疫来增强5天分割立体定向消融放疗的杀瘤效果
Hyunkyung Kim,Seok-Joo Chun,Sojung Sun et al.
Hyunkyung Kim et al.
Purpose: To investigate the potential role of low‒dose cyclophosphamide (Cy) as a radiosensitizer by evaluating its impact on the immune response and the abscopal effect of stereotactic ablative radiotherapy (SABR) throu...
Impact of TTF-1 Expression on the Prognostic Prediction of Patients with NSCLC with PD-L1 Expression Levels of 1% to 49%, Treated with Chemotherapy vs Chemoimmunotherapy: A Multicenter, Retrospective Study [0.03%]
TTF-1表达对PD-L1低表达(1%-49%)的NSCLC患者化疗和免疫治疗预后预测的影响：多中心回顾性研究
Naoya Nishioka,Tae Hata,Tadaaki Yamada et al.
Naoya Nishioka et al.
Purpose: Thyroid transcription factor 1 (TTF-1) expression is a useful predictor of treatment efficacy in advanced non-squamous non-small-cell lung cancer (NSCLC). This study aimed to evaluate whether TTF-1 could predict ...
Determinants of Prostate Cancer Screening in Korean Men: A Nationwide Study Using the Korean National Cancer Screening Survey 2023 [0.03%]
基于韩国全国癌症筛查调查的韩国男性前列腺癌筛查决定因素研究
Giap Viet Nguyen,Kyeongmin Lee,Hyeon Ji Lee et al.
Giap Viet Nguyen et al.
Purpose: Research on the prevalence of prostate cancer (PCa) screening and reasons for undergoing screening is limited. We aimed to identify the factors influencing PCa screening behavior and explore the underlying motiva...
Kinect-Based Mixed Reality Exercise Program Improves Physical Function and Quality of Life in Breast Cancer Survivors: A Randomized Clinical Trial [0.03%]
基于Kinect的混合现实锻炼程序可改善乳腺癌幸存者的身体功能和生活质量：一项随机临床试验
Byunggul Lim,Xinxing Li,Yunho Sung et al.
Byunggul Lim et al.
Purpose: Exercise is an effective non-pharmacological approach for alleviating treatment-related adverse effects and enhancing physical fitness in breast cancer survivors. A Kinect-based mixed reality device (KMR), with r...